TY - JOUR
AU1 - Meza, Monica Navarro
AU2 - Carrillo, Jesus Alcala Bejarano
AU3 - 
AB - Obesity and overweight are among the major health problems in the world today. The excessive accumulation of fat in adipose tissue is accompanied by low‐grade inflamma‐ tion, adipokine secretion dysregulation, oxidative stress, and an alteration of the secretion of gut hormones and food intake related to peptides. This is related to the development of cardiovascular diseases, which have been increased worldwide during the last 15 years approximately. The biomarkers are tremendously important to predict, diagnose, and observe the therapeutic success of common complex multifactorial metabolic diseases, such as obesity and cardiovascular diseases. This chapter presents a review of the most common biomarkers that have been used in the prevention, treatment, prognosis, and diagnosis of obesity and cardiovascular diseases. Keywords: biomarkers, cardiovascular disease, obesity, genetic markers, serum mark‐ ers 1. Introduction 1.1. Overweight and obesity Obesity and overweight have greatly become a stigma in most of the countries around the world since the middle of the past century, depending on the location, but it was not recognized as a disease until 2013 [1]. Its presence and the difficulty to eradicate it, it is mainly due to the multifactorial nature of this trait that depends on genetic and environmental factors as well 
TI - Role of Biomarkers in Medicine: Biomarkers, Obesity, and Cardiovascular Diseases
DA - 2016-08-17
UR - https://www.deepdyve.com/lp/unpaywall/role-of-biomarkers-in-medicine-biomarkers-obesity-and-cardiovascular-A3mLG9mFiR
DP - DeepDyve
ER -